Overview

Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients

Status:
Not yet recruiting
Trial end date:
2022-09-21
Target enrollment:
Participant gender:
Summary
Assess the effects of Sulforaphane supplementation in HIV patients that have achieved viral suppression.
Phase:
Phase 4
Details
Lead Sponsor:
Sunshine Specialty Health Care
Treatments:
Sulforaphane